Ken Griffin Novo Nordisk A S Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Novo Nordisk A S stock. As of the latest transaction made, Citadel Advisors LLC holds 1,356,200 shares of NVO stock, worth $199 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,356,200
Previous 933,300
45.31%
Holding current value
$199 Million
Previous $96.5 Million
80.36%
% of portfolio
0.03%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding NVO
# of Institutions
1,852Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3.1 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$2.02 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.92 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.76 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.74 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $332B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...